Moderna’s Shift to Cancer Company Lifts Stock Up 177%
New York Times · LC · trust 40/100
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Read the original at New York Times →
Open in TruthVane →